It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Standard clinical interpretation of myocardial perfusion imaging (MPI) has proven prognostic value for predicting major adverse cardiovascular events (MACE). However, personalizing predictions to a specific event type and time interval is more challenging. We demonstrate an explainable deep learning model that predicts the time-specific risk separately for all-cause death, acute coronary syndrome (ACS), and revascularization directly from MPI and 15 clinical features. We train and test the model internally using 10-fold hold-out cross-validation (n = 20,418) and externally validate it in three separate sites (n = 13,988) with MACE follow-ups for a median of 3.1 years (interquartile range [IQR]: 1.6, 3.6). We evaluate the model using the cumulative dynamic area under receiver operating curve (cAUC). The best model performance in the external cohort is observed for short-term prediction – in the first six months after the scan, mean cAUC for ACS and all-cause death reaches 0.76 (95% confidence interval [CI]: 0.75, 0.77) and 0.78 (95% CI: 0.78, 0.79), respectively. The model outperforms conventional perfusion abnormality measures at all time points for the prediction of death in both internal and external validations, with improvement increasing gradually over time. Individualized patient explanations are visualized using waterfall plots, which highlight the contribution degree and direction for each feature. This approach allows the derivation of individual event probability as a function of time as well as patient- and event-specific risk explanations that may help draw attention to modifiable risk factors. Such a method could help present post-scan risk assessments to the patient and foster shared decision-making.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Departments of Medicine (Division of Artificial Intelligence in Medicine), Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); University of Zielona Góra, Department of Interventional Cardiology and Cardiac Surgery, Collegium Medicum, Zielona Góra, Poland (GRID:grid.28048.36) (ISNI:0000 0001 0711 4236)
2 Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Departments of Medicine (Division of Artificial Intelligence in Medicine), Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
3 Oklahoma Heart Hospital, Department of Nuclear Cardiology, Oklahoma City, USA (GRID:grid.477640.6) (ISNI:0000 0000 9216 9049)
4 Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Departments of Medicine (Division of Artificial Intelligence in Medicine), Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); University of Calgary and Libin Cardiovascular Institute, Department of Cardiac Sciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
5 University of Manchester, Institute of Cardiovascular Science, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Manchester University NHS Foundation Trust, Department of Cardiology, Manchester Heart Institute, Manchester Royal Infirmary, Manchester, UK (GRID:grid.498924.a) (ISNI:0000 0004 0430 9101)
6 Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Departments of Medicine (Division of Artificial Intelligence in Medicine), Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Institute of Cardiology, Department of Interventional Cardiology and Angiology, Warsaw, Poland (GRID:grid.418887.a)
7 Assuta Medical Centers, Department of Nuclear Cardiology, Tel Aviv, Israel (GRID:grid.414003.2) (ISNI:0000 0004 0644 9941)
8 Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, Division of Cardiology, Department of Medicine and Department of Radiology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
9 Sacred Heart Medical Center, Oregon Heart and Vascular Institute, Springfield, USA (GRID:grid.416431.5) (ISNI:0000 0004 0453 0957)
10 University of Ottawa Heart Institute, Division of Cardiology, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)
11 University Hospital Zurich, Department of Nuclear Medicine, Cardiac Imaging, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
12 Yale University School of Medicine, Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
13 Cardiovascular Imaging Technologies LLC, Kansas City, USA (GRID:grid.47100.32)
14 Brigham and Women’s Hospital, Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)